Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative...

Related Keywords

United States ,Israel ,American ,Irina Koffler ,Dale Pfost ,Jack Lawler ,Barbara Lindheim ,Wadi Mor ,Lifesci Advisors ,Chemomab Therapeutics Ltd ,Systemic Sclerosis World Congress ,International Rheumatology Conference ,Company To Host Conference Call For Investors ,Nasdaq ,Development Rd Expenses ,Strategic Communications ,University Of Leeds ,Global Clinical Development Operations ,Host Conference Call ,Investors Today ,Chemomab Therapeutics ,Chief Executive Officer ,Vice President ,Global Clinical Development ,Scientific Officer ,Francesco Del Galdo ,Worse Prognosis ,Promising Novel Biological ,Systemic Sclerosis World ,Del Galdo ,Annual Oppenheimer Healthcare ,Cantor Fitzgerald Rare Orphan Disease Summit ,Ordinary Shares ,Depository Shares ,Private Securities Litigation Reform ,Sci Advisors ,Public Relations ,Consolidated Interim Statements ,Td ,